PNPT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.754400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.034400E-01
Normal-vs-Stage2
8.344400E-01
Normal-vs-Stage3
1.930440E-01
Normal-vs-Stage4
7.247600E-01
Stage1-vs-Stage2
9.826200E-01
Stage1-vs-Stage3
4.183800E-02
Stage1-vs-Stage4
8.327800E-01
Stage2-vs-Stage3
7.597700E-02
Stage2-vs-Stage4
8.873200E-01
Stage3-vs-Stage4
6.574400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.797400E-01
Normal-vs-AfricanAmerican
6.993200E-01
Normal-vs-Asian
8.756200E-01
Caucasian-vs-AfricanAmerican
6.802400E-01
Caucasian-vs-Asian
9.305800E-01
AfricanAmerican-vs-Asian
7.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.801400E-01
Normal-vs-Female
8.559400E-01
Male-vs-Female
9.324400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.564600E-01
Normal-vs-Age(41-60Yrs)
7.586000E-01
Normal-vs-Age(61-80Yrs)
9.274400E-01
Normal-vs-Age(81-100Yrs)
7.572800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.018600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.785800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.138400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.540400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.908600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.746200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.366200E-01
Normal-vs-Daily Drinker
9.772000E-01
Normal-vs-Weekly Drinker
8.921000E-01
Normal-vs-Occasional Drinker
5.891000E-01
Normal-vs-Social Drinker
7.000000E-01
Non Drinker-vs-Daily Drinker
5.503400E-01
Non Drinker-vs-Weekly Drinker
5.076200E-01
Non Drinker-vs-Occasional Drinker
8.279700E-02
Non Drinker-vs-Social Drinker
1.639050E-01
Daily Drinker-vs-Weekly Drinker
7.311600E-01
Daily Drinker-vs-Occasional Drinker
3.356200E-01
Daily Drinker-vs-Social Drinker
4.756000E-01
Weekly Drinker-vs-Occasional Drinker
7.756800E-01
Weekly Drinker-vs-Social Drinker
8.660000E-01
Occasional Drinker-vs-Social Drinker
8.592600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.483700E-02
Normal-vs-Grade 2
1.607630E-02
Normal-vs-Grade 3
5.062300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.205600E-02
Grade 1-vs-Grade 3
1.093910E-02
Grade 1-vs-Grade 4
9.483700E-02
Grade 2-vs-Grade 3
2.234400E-01
Grade 2-vs-Grade 4
1.607630E-02
Grade 3-vs-Grade 4
5.062300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.954400E-01
Normal-vs-NonDiabetic
8.837000E-01
Diabetic-vs-NonDiabetic
3.888000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.840400E-01
Normal-vs-NoPancreatitis
9.210800E-01
Pancreatitis-vs-NoPancreatitis
6.710600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.972200E-01
Normal-vs-N1
8.466000E-01
N0-vs-N1
7.986800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.659800E-01
Normal-vs-TP53-NonMutant
8.442200E-01
TP53-Mutant-vs-TP53-NonMutant
6.836100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
